Clinical Trial Update: A Study of Eptinezumab in Pediatric Participants With Episodic Migraine [Phase 3]

View source ↗

Summary

Phase 3 clinical trial in pediatric participants evaluating eptinezumab for episodic migraine; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• VYEPTI (eptinezumab)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Episodic Migraine | Phase 3 | Status: RECRUITING